Comprehensive Proteomics Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Severe Forms of Hypertrophic Cardiomyopathy

被引：0
|
作者：
Hartman, Heidi
Sherrid, Mark
Hasegawa, Kohei
Adlestein, Elizabeth
Swistel, Daniel
Tower-Rader, Albree
Fifer, Michael A.
Topkara, Veli K.
Maurer, Mathew S.
Reilly, Muredach P.
Shimada, Yuichi
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Hypertrophic cardiomyopathy; Proteomics;
D O I：
10.1161/circ.148.suppl_1.12080
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12080
引用
收藏
页数：3
相关论文
共 37 条
  • [1] Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy
    Lumish, Heidi S.
    Sherrid, Mark V.
    Janssen, Paul M. L.
    Ferrari, Giovanni
    Hasegawa, Kohei
    Castillero, Estibaliz
    Adlestein, Elizabeth
    Swistel, Daniel G.
    Topkara, Veli K.
    Maurer, Mathew S.
    Reilly, Muredach P.
    Shimada, Yuichi J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (20) : 1999 - 2011
  • [2] Comprehensive Proteomics Profiling of Myocardium Identifies Dysregulated Signaling Pathways in Hypertrophic Cardiomyopathy
    Lumish, Heidi S.
    Liang, Lusha
    Hasegawa, Kohei
    Adlestein, Elizabeth
    Swistel, Daniel
    Maurer, Mathew S.
    Reilly, Muredach P.
    Sherrid, Mark
    Shimada, Yuichi J.
    CIRCULATION, 2022, 146
  • [3] Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways
    Liang, Lusha W.
    Hasegawa, Kohei
    Maurer, Mathew S.
    Reilly, Muredach P.
    Fifer, Michael A.
    Shimada, Yuichi J.
    CIRCULATION-HEART FAILURE, 2023, 16 (06) : E010010
  • [4] Comprehensive Plasma Proteomics Profiling Identifies Signaling Pathways Dysregulated in Genotype-Positive versus GenotypeNegative Patients With Hypertrophic Cardiomyopathy
    Akita, Keitaro
    Hasegawa, Kohei
    Maurer, Mathew S.
    Rader, Albree Tower
    Fifer, Michael A.
    Topkara, Veli K.
    Reilly, Muredach P.
    Shimada, Yuichi
    CIRCULATION, 2023, 148
  • [5] Proteomics Profiling Reveals Molecular Pathways Enriched in Hypertrophic Cardiomyopathy
    Shimada, Yuichi J.
    Hasegawa, Kohei
    Kochav, Stephanie M.
    Mohajer, Pouya
    Fifer, Michael A.
    Gerszten, Robert
    CIRCULATION, 2018, 138
  • [6] Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy
    Shimada, Yuichi J.
    Raita, Yoshihiko
    Liang, Lusha W.
    Maurer, Mathew S.
    Hasegawa, Kohei
    Fifer, Michael A.
    Reilly, Muredach P.
    CIRCULATION-HEART FAILURE, 2021, 14 (07) : 777 - 787
  • [7] Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy
    Lee, C.
    Liang, L. W.
    Hasegawa, K.
    Maurer, M. S.
    Tower-Rader, A.
    Fifer, M. A.
    Reilly, M. P.
    Shimada, Y. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1724 - 1724
  • [8] Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity
    Shimada, Y. J.
    Raita, Y.
    Liang, L. W.
    Maurer, M. S.
    Hasegawa, K.
    Fifer, M. A.
    Reilly, M. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1777 - 1777
  • [9] Comprehensive Sequencing of Small Non-Coding RNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways
    Shimada, Yuichi J.
    Hasegawa, Kohei
    Fifer, Michael A.
    CIRCULATION, 2021, 144
  • [10] RNA-seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy
    Pisano, Annalinda
    Le Pera, Loredana
    Carletti, Raffaella
    Cerbelli, Bruna
    Pignataro, Maria G.
    Pernazza, Angelina
    Ferre, Fabrizio
    Lombardi, Maria
    Lazzeroni, Davide
    Olivotto, Iacopo
    Rimoldi, Ornella E.
    Foglieni, Chiara
    Camici, Paolo G.
    d'Amati, Giulia
    MICROCIRCULATION, 2022, 29 (08)
1234